Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bryant

Showing results (471-480 of 476) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 476 results.
Bioorganic & Medicinal Chemistry|January 1, 1997
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylationA K Mallams, F G Njoroge, R J Doll, et al.
Cancer Research|November 11, 1998
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic miceM Liu, M S Bryant, J Chen, et al.
Journal of Medicinal Chemistry|April 4, 1998
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazineA K Mallams, R R Rossman, R J Doll, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|November 25, 2022
A Learning Health System Approach to Long COVID CareAllison M Gustavson, Amanda Purnell, Marian Adly, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 26, 2023
<i>Strongyloides</i> questions-a research agenda for the futureReem Al-Jawabreh, Roy Anderson, Louise E Atkinson, et al.
Journal of Exercise Science and Fitness|January 23, 2023
Physical literacy in Europe: The current state of implementation in research, practice, and policyJohannes Carl, Anna S Bryant, Lowri C Edwards, et al.
Pageof 48

Showing results (471-480 of 476) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 476 results.
Bioorganic & Medicinal Chemistry|January 1, 1997
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylationA K Mallams, F G Njoroge, R J Doll, et al.
Cancer Research|November 11, 1998
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic miceM Liu, M S Bryant, J Chen, et al.
Journal of Medicinal Chemistry|April 4, 1998
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazineA K Mallams, R R Rossman, R J Doll, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|November 25, 2022
A Learning Health System Approach to Long COVID CareAllison M Gustavson, Amanda Purnell, Marian Adly, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 26, 2023
<i>Strongyloides</i> questions-a research agenda for the futureReem Al-Jawabreh, Roy Anderson, Louise E Atkinson, et al.
Journal of Exercise Science and Fitness|January 23, 2023
Physical literacy in Europe: The current state of implementation in research, practice, and policyJohannes Carl, Anna S Bryant, Lowri C Edwards, et al.
Pageof 48